About
Hepatitis D Treatment
Areas of Focus
Categories
Generic DrugRussia
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
1,116
By Phase
NA: 2PHASE2: 2PHASE1/PHASE2: 2
By Status
COMPLETED: 4RECRUITING: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06358391Collaborator
To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.
NARecruiting
70 participants
Started: Aug 21, 2024 · Completed: Mar 31, 2025
NCT05806346Collaborator
Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
NARecruiting
764 participants
Started: Aug 1, 2023 · Completed: Jun 30, 2025
NCT02888106Lead Sponsor
Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent
PHASE2Completed
90 participants
Started: Apr 30, 2016 · Completed: Oct 30, 2020
NCT03546621Lead Sponsor
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
PHASE2Completed
120 participants
Started: Feb 16, 2016 · Completed: Jan 31, 2018
NCT02637999Lead Sponsor
Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection
PHASE1/PHASE2Completed
24 participants
Started: Feb 13, 2014 · Completed: Jan 21, 2016
Locations (1)
Headquarters
Moscow, Russia
Map
Loading map...